Global Cervical Cancer Screening Market to Reach USD 7 Bn by 2020, States Renub Research in New Study Available at MarketPublishers.com
22 Feb 2017 • by Natalie Aster
LONDON – Globally, the rising incidence of cervical cancer is encouraging growth of the global cervical cancer screening market. The world’s cervical cancer market is slated to see the tremendous growth in the next years and reach the USD 7 billion mark by the year 2020.
North America is currently the largest regional cervical cancer market worldwide with a lion’s share of almost 50% of the global market for cervical cancer. Country-wise, the U.S. together with Japan capture a share of over 50% of the overall market. In Europe, the UK and France are leading country-wide markets for cervical cancer. As of APAC, it holds the highest share in cervical cancer screening population, with Indonesia, China and India accounting for the largest cervical cancer test population in the region.
New Renub Research publication, “Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA) Forecast”, offers a deep analysis of the global cervical cancer screening market, uncovering data on patient population and mortality rates in 20 countries. The actual and untapped number of patients and the current market scenario globally and on the national level are examined here. It provides the market analysis on the basis of the key regions (North America, APAC, Europe). Moreover, the research report highlights historical performance during 2001-2016 as well as outlines future possible trends and prospects of the market development along with forecasts through 2020.
Other new research reports provided by Renub Research are available its page at MarketPublishers.com.